Pharmacokinetic advantage of intra-arterial hepatic oxaliplatin administration: comparative results with cisplatin using a rabbit VX2 tumor model.

Pharmacokinetic advantage of intra-arterial hepatic oxaliplatin administration: comparative results with cisplatin using a rabbit VX2 tumor model.

Item
http://www.wikidata.org/entity/Q44943010
A phase 1 study of hepatic arterial infusion of oxaliplatin in combination with systemic 5-fluorouracil, leucovorin, and bevacizumab in patients with advanced solid tumors metastatic to the liver.What is the potential role of hepatic arterial infusion chemo-therapy in the current armamentorium against colorectal cancer.In vivo assessment of intratumoral aspirin injection to treat hepatic tumors.Postoperative prophylactic hepatic arterial infusion chemotherapy for stage III colorectal cancer: a retrospective study.Evaluation of the clinical relevance of body composition parameters in patients with cancer metastatic to the liver treated with hepatic arterial infusion chemotherapy.Role of intra-arterial hepatic chemotherapy in the treatment of colorectal cancer metastases.Meeting the biologic challenge of colorectal metastases.Locoregional therapies for metastatic colorectal carcinoma to the liver--an evidence-based review.The state of regional therapy in the management of metastatic colorectal cancer to the liver.Treatment Options in Colorectal Liver Metastases: Hepatic Arterial Infusion.Hepatic arterial infusion of gemcitabine-oxaliplatin in a large metastasis from colon cancer.Liver-directed chemotherapy of cetuximab and bevacizumab in combination with oxaliplatin is more effective to inhibit tumor growth of CC531 colorectal rat liver metastases than systemic chemotherapyAntitumoural hydroxyapatite nanoparticles-mediated hepatoma-targeted trans-arterial embolization gene therapy: in vitro and in vivo studies.Phase II Study of Sorafenib Combined with Concurrent Hepatic Arterial Infusion of Oxaliplatin, 5-Fluorouracil and Leucovorin for Unresectable Hepatocellular Carcinoma with Major Portal Vein Thrombosis.Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973)
P2860

Pharmacokinetic advantage of intra-arterial hepatic oxaliplatin administration: comparative results with cisplatin using a rabbit VX2 tumor model.

Item
http://www.wikidata.org/entity/Q44943010
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Pharmacokinetic advantage of i ...... sing a rabbit VX2 tumor model.
@en
Pharmacokinetic advantage of i ...... sing a rabbit VX2 tumor model.
@nl
type
label
Pharmacokinetic advantage of i ...... sing a rabbit VX2 tumor model.
@en
Pharmacokinetic advantage of i ...... sing a rabbit VX2 tumor model.
@nl
prefLabel
Pharmacokinetic advantage of i ...... sing a rabbit VX2 tumor model.
@en
Pharmacokinetic advantage of i ...... sing a rabbit VX2 tumor model.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Pharmacokinetic advantage of i ...... sing a rabbit VX2 tumor model.
@en
P2093
P304
P31
P356
10.1097/01.CAD.0000131684.06390.FE
P433
P478
P50
P577
P698